Satellite symposium at the 26th Annual Meeting of the International BFM Study Group
Invitation
Current status of T-cell engaging
immunotherapy in paediatric ALL:
challenges and opportunities
Thursday 7 May 2015, 17.00–18.00
Helia Congress Hotel, Budapest, Hungary
Current status of T-cell engaging immunotherapy in
paediatric ALL: challenges and opportunities
Thursday 7 May 2015, 17.00–18.00
Helia Congress Hotel, Budapest, Hungary
Programme
Chair: Professor Franco Locatelli, Italy
Welcome and introduction
Franco Locatelli, Italy
An update on clinical data with T-cell engaging immunotherapy in
children with relapsed/refractory ALL
Lia Gore, USA
The potential of T-cell engaging immunotherapy in children
relapsing post-transplant
Rupert Handgretinger, Germany
Considerations for identifying and managing adverse events associated
with novel immunotherapeutic approaches
Arend von Stackelberg, Germany
Amgen (Europe) GmbH
Dammstrasse 23
CH-6300 Zug
Switzerland
www.amgen.com
© 2015 Amgen Inc. All rights reserved.
EUHQ-NP-103-0315-103858. 03.2015